MedLumics Names VC Veteran James Greene CEO

MedLumics appointed James Greene as its CEO and Giovanni Leo to the board of directors. The Madrid-based company expects the two industry veterans to carry it through the its next phase of growth – commercialization of the AblaView AF catheter.

MedLumics SL has named James Greene, a partner with Dublin venture capital firm Seroba Lifesciences, as its new CEO. Greene takes over the CEO job from MedLumics’ founder, Eduardo Margallo, who will stay with the company as its chief operating officer.

Greene's task will be to lead the Madrid-based company in commercializing its AblaView optically guided, radiofrequency atrial fibrillation catheter. AblaView...

More from Leadership

More from Medtech Insight